BALCHEM CORP - 10-Q Summary (Period Ended Sep 30, 2005)
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Balchem Corporation for the period ended September 30, 2005. The company develops, manufactures, and markets specialty performance ingredients for the food, feed, and medical device sterilization industries. Operations are divided into three segments: Specialty Products, Encapsulated/Nutritional Products, and BCP Ingredients.
Key Financial Metrics
| Metric | 9 Months Ended Sep 30, 2005 | 9 Months Ended Sep 30, 2004 |
|---|---|---|
| Net Sales | $59,969 | $49,449 |
| Gross Profit | $21,943 | $17,855 |
| Gross Margin % | 36.6% | 36.1% |
| Net Earnings | $8,322 | $5,977 |
| Diluted EPS | $1.04 | $0.78 |
| Operating Cash Flow | $9,827 | $8,788 |
| Cash & Equivalents (End) | $10,723 | $17,330 |
| Total Debt | $0 | $0 (Term loan prepaid Dec 2004) |
| Working Capital | $24,768 | $23,505 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21.3% year-over-year to $59.97 million. Growth was driven by the BCP Ingredients segment (+53.5%) and the Encapsulated/Nutritional Products segment (+24.9%).
- Acquisition Impact: The June 30, 2005 acquisition of assets from Loders Croklaan USA, LLC contributed approximately $1.8 million to sales in the Encapsulated/Nutritional segment. Goodwill increased by $6.96 million to a total of $13.33 million.
- Profitability: Net earnings rose 39.2% to $8.32 million. Operating expenses as a percentage of sales decreased from 16.8% to 14.8%.
- Interest Expense: Interest expense dropped significantly to $6 (from $174) due to the prepayment of the company's term loan in December 2004.
- Cash Position: Cash and cash equivalents decreased by $2.01 million, primarily due to $11.42 million in cash used for the Loders Croklaan acquisition.
Guidance, Outlook, and Risks
- Subsequent Acquisition: On November 2, 2005, the company entered a definitive agreement to acquire Chelated Minerals Corporation (CMC) for $17.35 million. Closing is anticipated in Q4 2005.
- Stock Repurchase: The board authorized an extension of the stock repurchase program for up to 600,000 additional shares. 3,300 shares were repurchased in Q3 2005, and 24,800 in October 2005.
- Accounting Changes: The company is evaluating the impact of SFAS No. 123(R) regarding share-based payments, effective Jan 1, 2006. No stock-based compensation cost is currently reflected in net earnings.
- Risks: Success in the BCP segment depends on maintaining a low-cost position in a competitive marketplace. The Encapsulated segment relies on customer product launches and dairy industry economics.
Investor Verification Checklist
- Verify the closing date and final purchase price of the Chelated Minerals Corporation (CMC) acquisition.
- Monitor the integration of the Loders Croklaan assets and the realization of expected cost savings.
- Review the impact of SFAS 123(R) adoption on future net earnings and EPS in the 2006 fiscal year.
- Track the volume of stock repurchases under the extended program and its effect on share count.
- Assess the contingent payment obligations related to the Loders Croklaan acquisition based on future sales volumes.